Levocabastine (Livostin) Eye drops: Funding issue

Livostin eye drops not currently funded

We have been alerted to a packaging change for the partially funded levocabastine (Livostin) eye drops 0.5 mg per ml, which included a change of Pharmacode.

The product with the new Pharmacode is now in pharmacies. This change means the specific product being dispensed is not listed in the Schedule so pharmacies cannot claim for it.

Unfortunately, there was a misunderstanding with the supplier about whether the change needed to be notified to Pharmac.

The previous Livostin Pharmacode was 799882, the new Pharmacode is 2701405.

The new Livostin has been reviewed by and registered with Medsafe.

It will be partially funded again 

As soon as we were alerted to the issue, we reached out to the supplier. The new Pharmacode for Livostin eye drops will be listed again from 1 November 2025. The subsidy will remain the same.

What does this mean?

For any pharmacy dispensing Livostin with the new Pharmacode, they will need to either charge the full price or the person will need a new prescription for a funded product. 

We are sorry for any inconvenience caused. We have sought to put this right as soon as we learned of the problem. Unfortunately, we cannot list products on the Schedule outside of the regular monthly cycle.

Who to contact

If you have questions about this issue, email enquiry@pharmac.govt.nz

Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.

Sign up to our email list for regular emails about supply issues and more(external link)